Article
High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort.
The Journal of antimicrobial chemotherapy - 1 Jun 2018
Charpentier Charlotte, Peytavin Gilles, Lê Minh P, Joly Véronique, Cabras Ornella, Perrier Marine, Le Gac Sylvie, Phung Bao, Yazdanpanah Yazdan, Descamps Diane, Landman Roland
Abstract excerpt
Objectives: To assess, in a clinical cohort, the efficacy of switching current ART in virologically suppressed patients to a dolutegravir-based regimen, regardless of the genotypic susceptibility score (GSS). Patients and methods: This was an observational single-centre study assessing ART-treated patients with plasma viral load (pVL) <50 copies/mL who were switched to a dolutegravir-based regimen with 1 year of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.